GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the William E. Proudford Sickle Cell Fund presented the company with its 2012 Unsung Hero Award last night. The award was presented during the organization’s 7th Annual “Rockin’ the Red” Fundraiser which was held at the Legg Mason World Headquarters, in Baltimore, Maryland.
